Improving Screening and Outcomes for Postpartum Depression by Jahn, Elizabeth
University of North Dakota
UND Scholarly Commons
Nursing Capstones Department of Nursing
8-1-2015
Improving Screening and Outcomes for
Postpartum Depression
Elizabeth Jahn
Follow this and additional works at: https://commons.und.edu/nurs-capstones
Part of the Nursing Commons
This Capstone is brought to you for free and open access by the Department of Nursing at UND Scholarly Commons. It has been accepted for inclusion
in Nursing Capstones by an authorized administrator of UND Scholarly Commons. For more information, please contact
zeineb.yousif@library.und.edu.
Recommended Citation
Jahn, Elizabeth, "Improving Screening and Outcomes for Postpartum Depression" (2015). Nursing Capstones. 43.
https://commons.und.edu/nurs-capstones/43
                                                               
  
IMPROVING SCREENING AND OUTCOMES FOR POSTPARTUM DEPRESSION 
 
by 
Elizabeth L. Jahn DNP (c), FNP 
Bachelor of Science, University of North Dakota, 2006 
Master of Science, Minnesota State University, Mankato, 2010 
 
A Capstone 




University of North Dakota 
 
In partial fulfillment of the requirements  
for the degree of  
Doctor of Nursing Practice 





















                                                                                                                                                                                                                        
 ii 
 
This capstone, submitted by Elizabeth L. Jahn in partial fulfillment of the requirements for 
the Degree of Doctor of Nursing Practice from the University of North Dakota, has been read 














This capstone is being submitted by the appointed advisory committee as having met all of 











                                                             
 iii 
PERMISSION  
Title  Improving Screening and Outcomes for Postpartum Depression  
Department  College of Nursing  
Degree  Doctor of Nursing Practice  
                         In presenting this capstone in partial fulfillment of the requirements for graduate 
degree from the University of North Dakota, I agree that this university shall make it freely 
available for inspection. I further agree that permission for extensive copying for scholarly 
purposes may be granted by the professor who supervised my capstone work or, in her 
absence, by the Chairperson of the department.  It is understood that any copying or 
publication or other use of this capstone or part thereof for financial gain shall not be allowed 
without my written permission. It is also understood that due recognition shall be given to me 
and to the University of North Dakota in any scholarly use which may be made of any 
material in my capstone.  
 
Elizabeth L. Jahn 










Postpartum depression affects an estimated 20% of all mothers.  The World Health 
Organization has identified major depression as the fourth leading cause of burden among 
all diseases with an estimated cost to the United States of $30 billion to $50 billion in lost 
productivity and direct medical costs annually.  Standardized screening for postpartum 
depression is lacking, or in some cases non-existent at many health care facilities in the 
United States placing mothers, their children, families, and communities at increased 
risks for the adverse effects of postpartum depression.  These effects include increased 
childhood developmental delays, increased neglect and child maltreatment, poor health 
outcomes for mothers and children, and sometimes death.  Education on postpartum 
depression and implementation of standardized screening for postpartum depression 
using the Edinburgh postnatal depression tool at a rural Midwest medical center was 
implemented to facilitate improved screening rates, identification of postpartum 
depression, and subsequent treatment.  Following completion of the DNP capstone, rates 
of screening and identification of postpartum depression were increased by 43%.  
Knowledge and comfort in recognition, discussion, and screening for postpartum 
depression increased by 67% among providers and nurses.  The DNP capstone provided 
an opportunity for clinical practice change among these healthcare providers and 
healthcare improvement for postpartum women and their families.  
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Improving Screening and Outcomes for Postpartum Depression 
Background and Significance 
Postpartum depression (PPD) is defined by the Diagnostic and Statistical Manual 
of Mental Disorders Fifth Edition (DSM-5) as a depressive episode with moderate to 
severe intensity that begins four weeks after delivery (American Psychiatric Association 
[APA], 2013), but can occur up to one year following the birth of the baby (American 
Congress of Obstetricians and Gynecologists [ACOG], 2013).  While the onset can vary, 
typically postpartum depression is identified or diagnosed between one and six weeks 
postpartum.  Prevalence is higher in those women who were diagnosed with depression 
during or prior to their pregnancy.  While every woman is susceptible to postpartum 
depression, certain risk factors exist and correlate with higher rates of postpartum 
depression.  Some of the most commonly cited risk factors for PPD include women who 
are unmarried, have low socioeconomic status, are adolescents, have completed less 
education, are mothers of premature infants, have had an unplanned or emergency 
cesarean delivery, have had a previous diagnosis of depression or PPD, or are mothers of 
infants with disabilities or medical complications (Pessagno & Hunker, 2013). 
Clinical manifestations of PPD include inability to sleep or sleeping too much; 
mood swings; changes in appetite; fear of harming self or the infant; extreme concern and 
worry about the baby; sadness or excessive crying; feelings of doubt, guilt and 
helplessness; difficulty concentrating and remembering; loss of interest in hobbies and 
usual activities; and recurrent thoughts of death which may include suicidal ideation 
(Patel, et al. 2012).  Duration of effects for those who suffer from PPD can range from 
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months to a lifetime, making early identification and intervention of great importance for 
these women.   
The 2013 preliminary number of births for the United States was 3,932,181.  
Approximately 400,000 of those infants are born to mothers who are depressed (CDC, 
2010) and at least fifteen million children in the United States are cared for by parents 
suffering from depression (Chrisler, Blasbert, Forry & Tout, 2013).  Based on self-
reported questionnaires and clinical interviews, prevalence of PPD is estimated to affect 
5.2% to 74% of postpartum women in developed countries (Norhayati, Nik Hazlina, 
Asrenee & Wan Emilin, 2015).  According to a review of statistics from the Centers for 
Disease Control (CDC), National Institute of Health (NIH), United States Department of 
Health and Human Services, American Psychological Association and American 
Congress of Gynecology and Obstetricians, it has been consistently estimated and 
reported that the rate of postpartum depression in the United States is 15-20% of all 
postpartum women.  Comparatively, the Minnesota Department of Health (MDH), 
reported that postpartum depression and anxiety affect approximately 20% of Minnesota 
women overall and close to 30% of Minnesota women living within low-income 
communities (MDH, 2015).  State of Minnesota survey data indicated approximately one 
in ten new mothers in Minnesota experienced major depression symptoms within the first 
year of her baby’s life.  The state of Minnesota reported 64,852 live births in 2013 (CDC, 
2015).   This equates to approximately 15,000 Minnesota mothers and infants who 
experience the adverse effects of maternal depression each year.   
  




The mental health of a mother has a ripple effect with potential to negatively 
impact the cognitive, developmental, and physical health of the child as well as her entire 
family (Selix, 2015).  If PPD is not recognized and addressed maternal depression and 
anxiety can interfere with critical maternal interactions, maternal infant attachment and 
nurturing that are crucial to stimulating brain development, including lower rates of 
breastfeeding.  This in turn also negatively affects overall maternal quality of life, marital 
and personal relationships, and children’s social and cognitive developmental outcomes 
(Letourneau, Dennis, Benzies, Duffett-Leger et al., 2012). Suicide has even been 
documented as a potential consequence of PPD (Schaar & Hall, 2013).   
Financial impact.  It is difficult to calculate exact costs associated with PPD, 
however reducing the prevalence of untreated maternal depression is likely to have 
several short and long term financial implications.  High personal as well as public costs 
are associated with maternal depression in early childhood.  Further consequences of 
unrecognized postpartum depression accounts for more lost days from work and higher 
medical costs for the mother and her child.  Women of childbearing age represent 48% of 
the United States workforce and the majority of women who are working during 
pregnancy will return to work during the first year of the infant’s life.  The labor force 
participation rate of mothers with children under 18 years of age was 69.9 percent in 
2013, 61.1 percent for mothers with children under three years of age, and 57.3 percent 
for mother of infants or those less then twelve months of age (2013 annual averages).  In 
addition, depressed mothers are more likely to be unemployed (20% vs. 8%) and less 
likely to be employed full time (40% vs. 52%) when compared to mothers who aren’t 
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depressed (Ertel, Rich-Edwards & Koenen, 2011).  Overall, the time demands placed on 
a working mother and caring for an infant or young child are both physically and 
emotionally demanding, especially during the first year of the infants’ life making these 
women particularly more vulnerable to depression.   
 Failure of the current system to recognize and intervene with maternal depression 
early has further financial implications.  In Minnesota it is estimated that the yearly two-
generation cost to the state’s economy of not treating depression in each mother is at least 
$23,000 per mother.  Secondary financial effects of maternal depression like higher rates 
of special education for children, chronic health care costs and lost tax revenues from lost 
work days, cannot all be quantified meaning that $23,000 per mother suffering from 
depression is likely an underestimation (Children’s Defense Fund, 2011).    
While the prevalence of PPD is consistently shown to be 15-20% of U.S. women, 
and up to 30% in particular populations, data related to the cost effectiveness of screening 
and prevention are lacking. Further, a lack of focus on prevention, screening and early 
intervention for postpartum depression is consistently cited in the literature. In order to 
determine the cost benefit of such change in clinical practice, research in this area is 
needed.  There is however, a vast amount of documentation and proven financial benefit 
to the healthcare system for screening for depression in general.  It is cited that 
depression accounts for more than $43 billion in medical care costs and $17 billion in lost 
productivity annually (Maurer & Darnall, 2012).  Depression is projected to become the 
second largest cause of disability by 2020.  These statistics and data have motivated 
guidelines and screening changes within healthcare.   
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Screening: Lack of Consensus  
The United States Preventative Services Task Force (USPSTF) gives a grade ‘B’ 
clinical recommendation for use of the PHQ-2 as an accurate screening for depression in 
adolescents, adults and older adults when staff-assisted depression care supports are in 
place to assure accurate diagnosis, effective treatment, and follow-up (Maurer & Darnall, 
2012).  However, national guidelines specific to screening for PPD are much less clear, 
and consensus and agreement are lacking. The USPSTF does not have a recommendation 
for or against screening for postpartum depression. The American Academy of Family 
Physicians has no specific recommendations for postpartum depression and follows the 
general USPSTF recommendations for screening. 
The most recent update from ACOG in May 2015 stated that although definitive 
evidence of benefit is limited, it is recommended that clinicians screen patients at least 
once during the perinatal period for depression and anxiety symptoms using a 
standardized, validated tool.  Also in 2015, a newly added developmental objective for 
Healthy People 2020 recognized the need to decrease the proportion of women delivering 
a live birth who experience postpartum depressive symptoms.  Finally, the American 
College of Nurse Midwives (ACNM) supports universal screening, treatment, and/or 
referral for depression in women as a part of routine primary health care.  
Screening for PPD has significant room for improvement in the United States.  
Inconsistency and lack of consensus regarding best practice for this screening have 
created barriers, along with low rates of screening and recognition of this as a significant 
health problem for women, their children, and families.  This same gap in clinical 
practice was also recognized by the DNP student investigator within a rural healthcare 
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center in the Midwest.  Thus the DNP capstone was implemented as an opportunity for 
clinical practice change among healthcare providers and healthcare improvement for 
postpartum women and their families. 
Theoretical Framework 
 The theoretical foundation for this DNP capstone is the Theory of Transition by 
middle range theorist, Afaf Meleis. Dr. Meleis notes that the transition a woman makes 
during the postpartum period is complex and multidimensional.  Role change, 
physiological changes and relationship changes create potential for major postpartum 
depression to emerge.  How each woman perceives herself throughout this transition may 
also impact her experience and influence whether or not she will experience increased 
difficulty throughout this process.  The longer a woman remains in the transitional period 
with negative disruption, an even greater potential negative impact and disruption exists 
for the mother, her infant, her family and community. Through early recognition of 
disruption in their own human perception of the lived experience, transitions are likely to 
maintain fluency and increase the level of engagement from nursing, providers and 
patients. 
  It is during these critical transition points and events such as childbirth or events 
surrounding pregnancy that screening should serve as an intervention.  Screening for 
postpartum depression has potential to reduce or eliminate a negative perceived role 
insufficiency by the mother and instead positively supplement and clarify the role and 
transition the mother is experiencing.  If a woman is appropriately screened and 
subsequently identified as having PPD or found to be at a high risk for PPD, early 
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intervention can occur from the healthcare providers and system to encourage and 
promote the healthiest and safest transition for the mother, her child and family.   
A proven effective screening tool for postpartum depression, The Edinburgh Postnatal 
Depression Scale (EPDS) (Cox, Holden & Sagovskey, 1987) already exists but it is 
underutilized in clinical practice secondary to a lack of provider knowledge about 
screening for PPD, a lack of supporting consensus regarding screening guidelines, and 
limited routine healthcare encounters with women during the postpartum period.  If 
healthcare providers can recognize these obstacles, improved efforts can be taken to 
direct appropriate screening and improve outcomes for women, children and the 










Adapted from Meleis, A. Sawyer, L., Im, E., Massias, D., & Schumacher, K. (2000)   
Literature Review 
This literature review examined current guidelines and practices for postpartum 





Screen for PPD 
with EPDS 
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options and guidelines were also searched.  Several search engines were used including 
CINAHL, PubMed, Med Line, Psychinfo, Science Direct, Google Scholar and Cochrane 
databases.  Keywords used in the search included postpartum, depression, postnatal 
depression, prevalence, incidence, screening, Edinburgh Postnatal Depression Scale, 
suicide, pregnancy, and treatment.  The searches identified hundreds of related materials 
and the search was narrowed with the following primary articles utilized for purposes of 
this literature review.  Articles selected were peer reviewed with dates ranging from 
2007-2015.  
Postpartum Mood Disorder Spectrum 
 Postpartum depression is defined as a mood disorder that can affect women after 
childbirth.  The spectrum of emotional disruption a woman can experience after 
childbirth ranges from its mildest, most common form of ‘baby blues’ to its most extreme 
form, postpartum psychosis.  Rates of postpartum depression are consistently estimated 
to be 20% of all postpartum women although diagnosis of PPD is challenging given the 
fact that changes in sleep patterns, appetite, and excessive fatigue are often routine 
following delivery (Liberto, 2012; Pearlstein, Howard, Salisbury & Zlotnick, 2009).   
Determining whether a woman is experiencing postpartum depression versus 
what the literature refers to as ‘baby blues’ can be difficult.  Baby blues is a term that was 
created to describe the common symptoms of anxiety, irritability, and weepiness related 
to the birth of a child, most often linked to the abrupt hormonal changes that occur 
following childbirth.  This occurs in 50-85% of woman following delivery.  It peaks 
around the fourth day and resolves by the tenth day following delivery.  The ‘baby blues’ 
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are considered a normal physiological response to childbirth while a diagnosis of 
postpartum depression is not.   
On the other end of the spectrum, postpartum psychosis is a rare illness that 
occurs in approximately one to two out of every 1,000 deliveries, or approximately 0.1% 
of all births.  Symptoms of postpartum psychosis include delusions or strange beliefs, 
hallucinations, hyperactivity, extreme irritation, paranoia or suspiciousness, rapid mood 
swings or difficulty communicating at times.  Of women who experience postpartum 
psychosis there is a 5% suicide rate and 4% infanticide rate associated with the illness 
(Sit, Rothschild & Wisner, 2006). 
The DSM5 requires symptom onset to occur during pregnancy or within the four 
weeks following delivery to meet criteria for diagnosis of PPD (APA, 2013).  Many 
disagree with this classification and support longer time frames, up to twelve months 
postpartum for diagnosis and classification of PPD (Bobo & Yawn, 2014).  A major 
depressive disorder is diagnosed when a person exhibits five or more of the following 
symptoms: depressed mood; markedly diminished interest or pleasure in an activity; 
appetite disturbance; sleep disturbance; physical agitation or psychomotor retardation; 
fatigue; feelings of worthlessness; diminished concern or inability to make decisions; and 
recurrent thoughts of death or suicide (APA, 2013).   
Mothers with postpartum depression experience feelings of extreme sadness, 
anxiety, and exhaustion that may make it difficult for them to complete daily care 
activities for themselves or for others.  Postpartum depression does not have a single 
cause but likely results from a combination of physical and emotional factors. Postpartum 
depression does not occur because of something a mother does or does not do, which 
POSTPARTUM DEPRESSION  11 
 
 
places all women at risk for this problem (Lindahl, Pearson & Colpe, 2005).  Certain risk 
factors have been identified as placing some at even higher than average risk of 
developing PPD.  Low socioeconomic status, birth of first child, unmarried women, 
minorities, mothers of premature infants or infants with medical complications, and 
mothers who experience unplanned or emergency cesarean deliveries have been cited as 
having higher than average rates of PPD (Pearlstein, Howard, Salisbury & Zlotnick, 
2009).  In the absence of accepted guidelines for screening for postpartum depression, the 
individual clinician must determine how or even whether to screen for the illness 
(Goldsmith, 2007).    
Screening Guidelines  
The USPSTF does not have a recommendation for or against screening for 
postpartum depression. The American Academy of Family Physicians has no specific 
recommendations for postpartum depression and follows the general recommendations 
for screening of the USPSTF.   
The most recent update from the ACOG in May 2015 states that although 
definitive evidence of benefit is limited, ACOG recommends that clinicians screen 
patients at least once during the perinatal period for depression and anxiety symptoms 
using a standardized, validated tool.  They also state that although the adverse 
consequences of perinatal depression, as well as the benefits of its treatment, are clear, 
there is only limited evidence that screening to identify and treat this condition improves 
outcomes.   
According to ACOG, women diagnosed or recognized as being at risk for PPD 
with a positive screening assessment or through clinical judgment, require follow-up 
POSTPARTUM DEPRESSION  12 
 
 
evaluation and treatment if indicated.  Medical practices should have a referral process 
for identified cases.  Women with current depression or a history of major depression 
warrant particularly close monitoring and evaluation. 
 ACOG also suggested an objective for Healthy People 2020 targeted at 
decreasing the proportion of women delivering a live birth who experience postpartum 
depressive symptoms.  Healthy People is a set of goals and objectives with 10-year 
targets designed to guide national health promotion and disease prevention efforts to 
improve the health of all people in the United States.  The American College of Nurse 
Midwives supports universal screening, treatment, and/or referral for depression in 
women as a part of routine primary health care.  The ACNM has published position 
statements affirming the role of the Certified Nurse Midwife/Certified Midwife 
(CNM/CM) as a primary care provider and integrating depression care for all women 
(ACNM, 2002).  
Minnesota has become a very proactive state in supporting awareness of maternal 
mental health.  Since 2005 Minnesota has required hospitals to provide written 
information on postpartum depression before postpartum patients leave the facility.  Data 
from the statewide annual survey of new mothers, Pregnancy Risk Assessment 
Monitoring System (PRAMS), indicated that the law was successful in increasing rates at 
which women receive information about PPD.  Between 2002 and 2008 the percentage of 
women reporting they received information about the PPD before or after their babies’ 
birth increased from 77% to 90%.  Most recently on March 27th, 2015 Minnesota 
Governor Mark Dayton designated the month of May as Maternal Mental Health 
Awareness Month recognizing the importance of maternal mental health as an issue of 
POSTPARTUM DEPRESSION  13 
 
 
great concern for new parents, their families and to the State of Minnesota.  A need for 
heightened awareness and increased education of the incidence of pregnancy and 
postpartum mood and anxiety disorders as critical for all Minnesotans was noted.  The 
proclamation also noted that “many women are not adequately informed about, screened, 
or treated for pregnancy and postpartum mood and anxiety disorders due to the 
misunderstanding of the disorder, individuals being uninsured or underinsured, or lack of 
knowledge where to receive care” (Dayton, 2015). (see Appendix E) 
The current state of national healthcare places great emphasis on both prenatal 
and postnatal care.  In the executive summary of The State of Health Care Quality 2010, 
rationale for importance of postpartum follow up recognized that the postpartum visit is a 
chance to perform postpartum depression screenings among other tests.  This visit is cited 
as a chance for healthcare providers to converse with the mother to detect early problems 
with parenting skills.  The postpartum visit is also opportunity for follow-up with any 
problems that occurred during pregnancy, such as maternal diabetes (National Committee 
of Quality Assurance, 2010).  In addition, the postpartum visit is often the only follow-up 
visit a woman has with her own healthcare provider after the birth of her child or within 
the first year of her child’s life.  The next time she seeks medical care for herself is often 
not until her annual well woman visit more than a year later.  This further demonstrates 
the importance of the postpartum visit as possibly being an optimum opportunity to 
screen for and identify PPD as well as implement necessary observation and/or treatment 
for this condition.                         
Screening Tools  
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Several screening instruments have been validated for use during pregnancy and 
the postpartum period to assist with identifying patients with perinatal or postpartum 
depression. They include the Beck Depression Inventory, the Center for Epidemiologic 
Studies Depression Scale, the Postpartum Depression Screening Scale, the Patient Health 
Questionnaire 9 (PHQ-9), and the Edinburgh Postnatal Depression Scale (EPDS). 
  A review of the literature strongly suggests that the EPDS is the widely preferred 
screening tool.  The EPDS is a ten item self-report scale that was created by Cox, Holden 
& Sagovskey (1987).  This validated and well respected screening tool is utilized by 
many primary care providers, obstetricians and nurses across the United States to screen 
for PPD.  The EPDS takes less than five minutes to complete through interview or self-
report, has been translated into twelve languages, has a low required reading level, and is 
easy to score.  It also includes questions regarding anxiety symptoms, which are a 
prominent feature of perinatal mood disorders, and excludes constitutional symptoms of 
depression.  It is this exclusion of the constitutional symptoms that increases its 
specificity in screening for PPD.  According to the EPDS the optimal time to screen for 
PPD is between two and six weeks postpartum but it can be used during the entire 
perinatal period (Bobo & Yawn, 2014; Pearlstein, Howard, Salisbury & Zlotnick, 2009).  
With the exception of the Patient Health Questionnaire 9 (PHQ-9) and the Edinburgh 
Postnatal Depression Scale, the other screening instruments have at least 20 questions 
and, thus, require more time to complete and to score and are rarely cited in the literature 
as used for PPD screening.   
The EPDS and other screening tools available should not be considered a 
substitute for a detailed clinical interview and diagnostic tests where indicated.  They can 
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however provide a consistent approach and initial screening point for all postpartum 
women to help begin further conversation and assessment of symptoms.  With early and 
effective recognition of PPD, prompt treatment and intervention can be initiated to 
optimize therapy and ideally long term outcomes from this common and sometimes fatal 
problem (Angstman, 2013; Bobo & Yawn, 2014; Truitt, Pina, Person-Rennell & Yawn et 
al., 2012).  Healthcare professionals can increase health promotion and reduce suffering 
caused by PPD by providing appropriate education to individuals, employers, and 
policymakers on the harmful effects of postpartum depression (Selix, 2015).   
Advanced Practice Nurses  
Advanced practice nurses (APRNs) such as Family Nurse Practitioners (FNPs) 
are the primary care providers (PCPs) for millions of patients nationwide and are seeing 
more and more postpartum women in primary care settings.  According to a report 
published by the U.S. Department of Health and Human Services (2013, November), if 
the system for delivering primary care in 2020 were to remain fundamentally the same as 
today, there will be a projected shortage of 20,400 primary care physicians. The report 
goes on to recognize that under a scenario in which primary care nurse practitioners and 
physician assistants (PAs) are fully integrated into health care delivery, such as patient-
centered medical homes that emphasize team-based care, the projected shortage of 
20,400 primary care physicians in 2020 could be reduced to 6,400 primary care providers 
(HRSA, 2013). 
In a study of the screening practices of Family Nurse Practitioners (FNPs) done 
by Goldsmith (2007), results showed that while 84% of the responding FNPs saw at least 
one postpartum visit yearly, 42% did not screen for postpartum depression in any way.  
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The Translating Research into Practice for Postpartum Depression (TRIPPD) 
effectiveness study (2012) was a large practice-based effectiveness study that sought to 
determine the effect of a practice based training program for screening, diagnosis and 
management of depression in postpartum mothers.  Of the 2,343 women enrolled, 654 
had elevated postpartum screening scores on the EPDS.  These women were more likely 
to receive an appropriate diagnosis and therapy for postpartum depression which 
correlated to lower depressive symptoms at six and twelve months postpartum (Yawn et 
al., 2012).  The effect of developed screening programs for PPD on clinical outcomes 
however, may depend on a variety of factors including availability of adequate mental 
health resources, important non-clinical services such as transportation, child care, care 
management, lactation and parenting support, as well as insurance coverage (Bobo & 
Yawn, 2014).  
The significance of postpartum depression is multifactorial with implications for 
women and children across the country and around the world.  With implementation of 
standardized screening and focused efforts by healthcare providers, especially APRNs on 
early recognition of PPD, appropriate treatment can be implemented early to ensure 
improved outcomes for women, children and the entire family.             
Project Purpose 
 The DNP capstone was implemented at a rural medical center in the Midwest 
after noting that no standardized practice for PPD screening was currently in place at the 
center.  The overall goal for this DNP capstone was to as improve provider and nurse 
awareness of PPD and its negative effects, identify the importance of routine PPD 
screening, and implement a standardized screening tool for PPD within the center. 
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The outcomes for the capstone were:  
1. To increase staff comfort and knowledge about PPD and screening practices 
by 50% as evidenced by results of a pre and post-test given at a staff 
educational session held on January 28th, 2015. 
2. To increase the use of the EPDS by 25% as evidenced by its documented use in 
the electronic health record (EHR) at a woman’s postpartum visit in the center. 
Design and Methods 
Population 
The DNP capstone focused on a population of postpartum women ages 18 years 
or older treated at a rural medical center in the Midwest.  These postpartum women were 
evaluated between four and eight weeks following the birth of her child or at their 
scheduled postpartum visits at the center, which typically occurred at six weeks 
postpartum.    
Education     
Prior to capstone implementation, a retrospective chart audit evaluated 
documented rates of postpartum depression screening in patients’ charts from November 
1, 2014, to January 30, 2105.  The study began with a one-hour educational session 
conducted by the DNP student investigator for physicians, nurse practitioners and nurses 
held on January 28, 2015.  Participants were informed about the DNP capstone process 
and given postpartum depression information including statistics, current treatment 
guidelines and recommendations for early intervention as well as the most current 
treatment options.  Screening instruments were discussed and the EDPS was introduced 
as the instrument of choice for the DNP capstone.  Participants were educated on 
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appropriate use of the EPDS, as well as correct scoring of the tool and how to document 
results in the electronic health record (EHR).  It should be noted that the EPDS was 
already available within the center’s clinic, but the DNP student investigator needed to 
work with the informational technology staff to make it more provider friendly and easier 
for providers to access and complete during this process.   
A second, additional educational session was held with the clinics registered nurse 
(RN) health coaches.  The RN health coaches are in charge of evaluating providers’ clinic 
schedules on a daily basis as part of the Medical Home Model and were key stakeholders 
in the entire capstone process. Medical home is a team based collaborative approach to 
healthcare that provides comprehensive and continuous medical care to patients with the 
goal of obtaining maximum health outcomes, particularly in the areas of chronic disease 
(American Academy of American Physicians, 2015). This education session included an 
overview of the study and allowed for questions to be asked specific to their roles in the 
capstone process.  The RN health coaches agreed to identify scheduled postpartum visits 
and bring a copy of the EDPS tool to the nurse or provider reminding them of the visit 
and encouraging use of the screening tool on a daily basis.  The tool was given to the 
patient during the start of their clinic visit and collected by the provider or nurse when the 
patient completed it.  The tool was then electronically entered into the EHR by the 
provider, the nurse or the RN health coach depending on each providers’ preference.  
There was almost daily communication between the DNP student and the RN health 
coaches allowing for continued engagement and support during implementation.  
Recruitment 
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All nursing staff and providers in the center were invited to the educational 
session via email.  Direct communication was also used with the DNP student 
investigator and providers who were working on the day of the educational presentations.  
A voluntary pre and post-test with implied consent was given during the first educational 
session to all in attendance.  This pre and post-test was used to assess both comfort and 
knowledge in relation to postpartum depression, discussion of PPD with patients, as well 
as comfort with familiarity and use of the EPDS (See Appendix B).  Collected 
demographic data included identification of clinical role and whether or not the provider 
or nurse saw patients in their clinical role for postpartum visits. 
Methods   
The capstone used a one-group pre/post intervention design to investigate whether 
physician, APRN, and nurse participation in an educational session related to screening 
for PPD with the EPDS would improve PPD screening at a rural Midwest health center.  
The one group design was chosen for this study due to the small size of the clinic and the 
number of providers participating.  The educational session and materials were made 
available to all providers and appropriate nursing staff at the clinic to whom it would be 
applicable.  
 Following the educational session the implementation of the standardized 
screening took place from February 1, 2015, through April 30, 2015.  Even though the 
educational session was completed on January 28, 2015, the RN health coaches did not 
start screening providers’ schedules and distributing the EPDS to providers and nurses 
until the start of the capstone implementation on February 1, 2015.  During the three-
month capstone period it was requested that all patients presenting to the clinic for a 
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postpartum visit were to be screened for postpartum depression with use of the Edinburgh 
Postnatal Depression Scale. 
Data Collection 
Results of completed screening tools were then entered into patients’ electronic 
medical records by the provider, nursing staff or RN health coaches.  Following the three-
month period of data collection, a second retrospective chart review was completed to 
determine the number of patients who presented for postpartum visits during the study 
time frame and how many were screened for postpartum depression using the EPDS.  
These outcome objectives were measured through both primary ordinal data and nominal 
secondary data.  Data on providers’ and nurses’ current understanding, comfort and 
knowledge levels regarding postpartum depression as well as the Edinburgh postnatal 
depression tool, was collected from the pre and post-tests given at the initial educational 
session for staff.  An Excel spreadsheet created by the DNP student was used to record 
retrieved data (see Appendix H). Post intervention screening data was then compared to 
baseline screening data obtained prior to the staff educational session and implementation. 
Protection of Human Subjects 
Protection of human subjects was of paramount importance.  The Institutional 
Review Boards at both the center where the project took place and the University of 
North Dakota deemed this project to be exempt and approved the research project 
proposal.  Data collected through both retrospective chart reviews was done by either the 
project coordinator or IT staff.  The data was entered onto spreadsheets with no patient 
identifiers being recorded to protect confidentiality. Spreadsheets and questionnaires were 
kept in a locked file at the clinic during the entire duration of data collection and project 
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implementation.  All electronic data was kept on a secure office computer that was 
password protected and only accessible by the DNP student.   Standard IRB protocol will 
be followed for the data storage. 
Results and Interpretation 
The staff educational session was attended by 24 participants, with 24 completing 
some or all of the pre-test and post-test survey.  Of those participants, twenty (83.3%) 
identified themselves as nurses and four (16.7%) identified themselves as providers. 
Also, ten of twenty-four participants (41.7%) indicated that they did see postpartum 
patients.  Four of twenty-four (16.7%) indicated familiarity of the Edinburgh Postpartum 
Depression Scale.   Following the educational session, 100% of participants indicated 
familiarity with the tool, indicating a six-fold increase. 
The pre-test and post-test evaluation consisted of a combination of yes/no 
questions, and a five-point Likert scale that was used to identify whether or not 
respondents participated in the care of postpartum patients; their familiarity with the 
Edinburgh Postpartum Depression Scale; and their comfort levels with its use, 
interpretation of results and discussion of postpartum depression with patients.  To 
determine changed or improved comfort and knowledge in these areas, three questions on 
the pre-test were asked at the completion of the educational session for a post-test 
comparison. The single-group pre-test and post-test design was used to document which 
areas of comfort and knowledge improved.  
 At the start of the educational session only eleven participants indicated that they 
were familiar with the EPDS.  Prior to the educational session, four out of eleven (36.4%) 
participants indicated that they were either somewhat comfortable or very comfortable 
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using a postpartum evaluation tool; following the educational session, twenty-three out of 
twenty-four participants (95.8%) indicated that they were either somewhat comfortable or 
very comfortable using a postpartum evaluation tool, indicating a 163.5% increase.  
Using the test for a difference between proportions (with the Yates’ continuity 
correction), these pre-test and post-test percentage differences for practitioner comfort 
with the EPDS was statistically significant (p = .0003). 
 Prior to the educational session, fourteen of the twenty-one participants (66.7%) 
reported feeling either somewhat comfortable or very comfortable discussing postpartum 
depression with patients and three participants indicated they were not at all comfortable. 
Following the educational session, twenty of twenty-four participants (83.3%) reported 
that they felt either comfortable or very comfortable discussing postpartum depression 
with patients.  Using the test for a difference between proportions (with the Yates’ 
continuity correction), these pre-test and post-test percentage difference for practitioner 
comfort with the discussing PPD was not statistically significant (p = .1710). 
In a retrospective chart audit conducted from November 1, 2014, to January 31, 
2105, there were 57 documented postpartum visits to this particular clinic, none of which 
showed documentation using the Edinburgh Postnatal Depression Scale. At the 
completion of the study, a follow-up review was conducted from February 1, 2015, to 
April 31, 2015, during which time there were 43 recorded postpartum visits.  Nineteen 
(44%) of those visits had documented evidence of the Edinburgh postnatal depression 
tool in the electronic health record. 
Strengths and Limitation 
Stakeholder Buy-In   
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There were several key stakeholders identified throughout the capstone process.  
The buy in and support from the RN health coaches was paramount not only for 
successful implementation of the EPDS but for continuity and consistency of daily 
operations.  They worked side by side with the DNP student investigator had a genuine 
vested interest in improving care for the patients they serve.  The nurses, providers and 
administrators of the clinic were also strongly supportive of this capstone.  They had a 
vested interest throughout the entire planning, education and implementation of the study.  
Information technology staff assisted in a variety of collaborative ways with the DNP 
student.  They aided in the educational materials development though help with tips and 
tricks in navigation of the EHR and more efficient use of the EPDS electronically.  They 
collaboratively worked with the DNP student to aid with data collection and provided 
ongoing support throughout the entire capstone process. 
Organization  
The health care organization also provided great support to the DNP student 
investigator and readily accommodated the DNP capstone.  There was no charge to use 
the facility for the educational sessions and the organization also covered the cost of 
lunch for staff who attended the lunch-n-learn session.  The information technology staff 
also gave their time to aid in data retrieval as well as provided assistance with 
troubleshooting documentation questions and assistance with retrieval and input of 
patients completed EPDS in the EHR. 
Compliance with State Recommendations 
The current state of healthcare in this nation and  Minnesota’s proactive approach 
to quality postpartum care for women have highlighted the need to become more aware 
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of PPD and more diligent about screening for this condition.  This DNP capstone 
followed the same trend and provided an excellent opportunity for providers to 
participate in standardized screening for PPD.  No current standard for routine PPD 
screening existed in this center prior to this DNP capstone. This capstone demonstrated 
the collaborative efforts that are needed among healthcare providers at local and state 
levels to make an impact in identifying PPD.     
Limitations 
One limitation of the DNP capstone was the short time frame for data collection.  
Data collection was limited to three months.  A longer timeframe would have allowed for 
more postpartum visits to the clinic and in turn a larger number of data for analysis.  
Another limitation was a lower than anticipated turnout of providers at the staff 
educational lunch-n-learn session where the pre and post-test was administered.  It was 
anticipated that up to nine providers would attend.  A variety of reasons for the low 
attendance were identified including providers completing hospital rounds, providers out 
of clinic on the date of the educational session or scheduling conflicts.  Those who were 
unable to attend but who see postpartum women in the clinic were briefed individually by 
the DNP student on the study but did not complete the pre and post-test evaluation.  
Due to not having full Institutional Review Board (IRB) approval, the coordinator 
was unable to see the exact impact the screening had on patients.  Information on 
resulting interventions such as whether a medication was started, mental health referral 
took place, or what follow up was recommended was not able to be part of the data 
collection.  It would provide a greater demonstration of the benefit of screening if such 
data could have been obtained.  Unfamiliarity with the use of the EPDS within the 
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electronic health record was a limitation as well.  Staff indicated during the educational 
session they were not aware that the EPDS was available within the EHR.  Another 
limitation may have been that patients very likely could have been screened, but scores 
may not have been logged into the electronic medical record.  If the visit type was not 
coded as a postpartum visit or the ICD-9 code of V24.2, data retrieval may have been 
somewhat inaccurate as these are the visit types that were used by Information 
Technology staff to retrieve postpartum visit information during the designated 
timeframe.  
Implications and Future Direction 
This capstone was a pilot study that laid the groundwork for future 
implementation for PPD screening to be integrated as standard of care within the 
healthcare organization both at a local and system wide level.  There were no unexpected 
findings as a result of this study.  This DNP capstone is an excellent example of how 
increased rates of screening for postpartum depression can result from PPD education and 
implementation of a standardized screening protocol and tool.  Steps are being taken to 
continue this screening practice and staff has reported that some providers have continued 
the screening as a routine part of their practice.  The data demonstrated a 0% documented 
screening rate prior to implementation of the project suggesting that screening was not 
taking place.  The evidence is significant enough to promote the move for PPD screening 
as a standard of care change in this clinical practice. 
It will be suggested to local leadership that this screening practice be made the 
standard of care at this facility as well as other facilities within the larger organization.  
Education will continue to be provided to staff as needed with updated information 
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regarding postpartum depression, screening recommendations and any additional needs 
that may be indicated by staff regarding screening for PPD.   
This clinical practice change has implications for future projects.  The next step 
will be implementation of what is known as a ‘best practice alert’ for postpartum 
depression screening built into patients’ electronic medical records.  This will entail an 
automatic prompt to appear on the computer screen whenever a provider initiates 
documentation for a postpartum visit.  This is currently done for depression screening, 
colon cancer screening, mammography and vaccination reminders.  Advanced Practice 
Nurses are in an optimal position to influence positive clinical changes at the local, state, 
and national levels due to their extensive clinical experience, exceptional communication 
skills, and expertise in evidence based practice.  Their passion can be utilized to identify 
gaps in health care services and organizations, and to fill these gaps with positive clinical 
changing practices such as that discussed in this capstone.  This DNP student has plans to 
disseminate this study at American College of Nurse Midwifes’ 61st annual meeting and 
an abstract has already been submitted for review. 
Conclusion 
This DNP capstone highlights the need for a standardized approach for 
postpartum depression screening in the rural Midwest health care setting, especially given 
the current state of healthcare and state of Minnesota’s laws relating to PPD.  A vast 
array of research exists recognizing postpartum depression as a national problem with 
many negative implications for the mother, her child and family. The application of a 
consistent screening practice by health care providers has great potential to help alleviate 
POSTPARTUM DEPRESSION  27 
 
 
some of those problems and assist in the diagnosis and treatment of this psychologically 
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Your participation is voluntary and part of a DNP research study by Elizabeth Jahn, NP.  
You can choose not to participate or you may stop your participation at any time without 
penalty or loss of benefits to which you are otherwise entitled.  
 
Your decision whether or not to participate will not affect your current or future relations 
with Sanford Health 
 
Please choose one answer for each question below (check only one box for each 
question): 
 
1. I am a provider                                I am a nurse             
 
                                 Other  
 
 
100. Do you see patients for postpartum visits?                   
 
  Yes     No     Unsure 
 
100. Do you utilize a specific screening modality for postpartum depression? 
 
  Yes                 No              I do not see postpartum patients 
 
 
4. Are you familiar with the Edinburgh postpartum depression screening tool?   
 
  Yes 
  No 
  
5. If yes are you comfortable with how to use and interpret its results 
 
Very comfortable Somewhat comfortable Neutral Not comfortable at all  
 
 
6. Are you comfortable with discussing postpartum depression with patients?    
 
Very comfortable Somewhat comfortable Neutral Not comfortable at all  






Do not complete until the completion of the educational session 
 
 
7. Are you familiar with the Edinburgh postpartum depression screening tool?   
 
  Yes 
  No 
 
8. If yes are you comfortable with how to use and interpret its results 
 




9. Are you comfortable with discussing postpartum depression with patients?    
 




For the following questions, please indicate your agreement or disagreement with 
the following statements: 
 
 
10. I feel that all women should be screened for postpartum depression 
 
Strongly Disagree Mildly Disagree Neutral Mildly Agree Strongly Agree 
 
 






Thank you for your completion of this survey. 
 
Questions or concerns can be relayed to  
Elizabeth Jahn  
Elizabeth.jahn@sanfordhealth.org 























IRB Approval x         
Retrospective 
Chart Review 
x x x       
Staff education   x       
Implementation 
of screening 
   x x x    
Retrieve I Data       x   




     x x x  
Organizational 
approval 
X         






Q2 Pre:  Do you see patients for postpartum visits? 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Yes 10 41.7 41.7 41.7 
No 14 58.3 58.3 100.0 
Total 24 100.0 100.0  
 
Q3 Pre:  Do you utilize a specific screening modality for postpartum depression? 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Yes 1 4.2 4.2 4.2 
No 17 70.8 70.8 75.0 
I do not see postpartum patients 6 25.0 25.0 100.0 
Total 24 100.0 100.0  
 
 
Q3 Pre:  Are you familiar with the Edinburgh postpartum depression screening tool? 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Yes 4 16.7 16.7 16.7 
No 20 83.3 83.3 83.3 




Q1:  I am ___. 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Provider 4 16.7 16.7 16.7 
Nurse 20 83.3 83.3 100.0 
Total 24 100.0 100.0  
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Q4 Post:  Are you familiar with the Edinburgh postpartum depression screening tool? 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid Yes 24 100.0 100.0 100.0 
 
 
Q5 Pre:  If “yes” (to Q5), are you comfortable with how to use and interpret its results? 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Not Comfortable at All 3 12.5 27.3 27.3 
Neutral 4 16.7 36.4 63.6 
Somewhat Comfortable 1 4.2 9.1 72.7 
Very Comfortable 3 12.5 27.3 100.0 
Total 11 45.8 100.0  
Missing System 13 54.2   
Total 24 100.0   
 
 
Q5 Post:  If “yes” (to Q5), are you comfortable with how to use and interpret its results? 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Neutral 1 4.2 4.2 4.2 
Somewhat Comfortable 9 37.5 37.5 41.7 
Very Comfortable 14 58.3 58.3 100.0 
Total 24 100.0 100.0  
 
Q6 Pre:  Are you comfortable with discussing postpartum depression with patients? 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Not Comfortable at All 1 4.2 4.8 4.8 
Neutral 6 25.0 28.6 33.3 
Somewhat Comfortable 8 33.3 38.1 71.4 
Very Comfortable 6 25.0 28.6 100.0 
Total 21 87.5 100.0  
Missing System 3 12.5   
Total 24 100.0   




Q6 Post:  Are you comfortable with discussing postpartum depression with patients? 
 Frequency Percent Valid Percent Cumulative 
Percent 
Valid 
Neutral 4 16.7 16.7 16.7 
Somewhat Comfortable 10 41.7 41.7 58.3 
Very Comfortable 10 41.7 41.7 100.0 
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